-
Purdue Pharma L.P. et al v. Amneal Pharmaceuticals, LLC DC CAFC
- 1:13-cv-03372
- S.D.N.Y.
- Filed: 05/17/2013
- Closed: 04/09/2015
- Latest Docket Entry: 06/14/2022
- Judge: Sidney H. Stein
- PACER
3
Plaintiffs
1
Defendant
1
Accused
Product
1
Patent-in-Suit
693
Days in
Litigation
-
Purdue Pharma L.P. et al v. Amneal Pharmaceuticals, LLC DC CAFC
- 1:13-cv-03372
- S.D.N.Y.
- Filed: 05/17/2013
- Closed: 04/09/2015
- Latest Docket Entry: 06/14/2022
- Judge: Sidney H. Stein
- PACER
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Assigned Judge
Outcome Summary
Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 5 |
The controlled release oral dosage form of claim 1, wherein the aqueous liquid is water.
|
Invalid (103 and 112)
Entry 68 Entry 67 |
| 7 |
The controlled release oral dosage form of claim 1, wherein a viscosity of at least about 60 cP is imparted.
|
Invalid (103 and 112)
Entry 68 Entry 67 |
| 23 |
The controlled release oral dosage form of any of claims 2, 4, 5, 6 and 7, wherein the viscosity is obtained when the dosage form is subjected to tampering by crushing and dissolution in the aqueous liquid.
|
Invalid (103 and 112)
Entry 68 Entry 67 |
| 24 |
The controlled release oral dosage form of any of claims 2, 4, 5, 6 and 7, wherein the viscosity is obtained when the dosage form is subjected to tampering by dissolution in the aqueous liquid with heating greater than 45° C.
|
Invalid (103 and 112)
Entry 68 Entry 67 |
-
Infringement
Amneal Pharmaceuticals, LLC
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxycodone hydrochloride extended release tablet | US 8,337,888 B2 |
5, 7, 23, 24
|
Infringement
Entry 67
|